Who Owns Alto Neuroscience Stock?
NYSE: ANROHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 94.74%
- Held by insiders
- 4.26%
- Institutional holders
- 181
- Institutions 94.7%
- Insiders 4.3%
- Public and other 1.0%
Who owns Alto Neuroscience stock?
Institutional investors own about 94.7% of Alto Neuroscience's shares, spread across 181 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 4.26% of ANRO.
The largest institutional holders are Alpha Wave Global, LP (9.24%), Blackrock Inc. (6.80%) and Commodore Capital Lp (6.79%). Together, the top 10 institutions control 47.5% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their ANRO positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ANRO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Alpha Wave Global, LP | 3.71M | 9.24% | 0.0% |
| Blackrock Inc. | 2.73M | 6.80% | +28.5% |
| Commodore Capital Lp | 2.72M | 6.79% | 0.0% |
| Vanguard Capital Management LLC | 1.69M | 4.22% | +21.7% |
| Spruce Street Capital LP | 1.68M | 4.18% | +23.9% |
| Perceptive Advisors Llc | 1.61M | 4.01% | -19.9% |
| Adage Capital Partners GP L.L.C. | 1.60M | 3.99% | +315.6% |
| Vivo Capital, LLC | 1.36M | 3.39% | +12.5% |
| Franklin Templeton, Inc. | 993.49K | 2.48% | -2.0% |
| State Street Corporation | 946.04K | 2.36% | +37.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ANRO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.01M | 2.52% |
| iShares Trust-iShares Russell 2000 ETF | 836.52K | 2.09% |
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 347.90K | 0.87% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 346.62K | 0.86% |
| iShares Trust-iShares Russell 2000 Growth ETF | 298.27K | 0.74% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 287.03K | 0.72% |
| iShares Trust-iShares Biotechnology ETF | 279.35K | 0.70% |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 251.09K | 0.63% |
| T. Rowe Price Health Sciences Fund, Inc. | 228.06K | 0.57% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 179.26K | 0.45% |
Frequently asked questions
Who is the largest shareholder of Alto Neuroscience?
Alpha Wave Global, LP is the largest institutional shareholder of ANRO, owning 9.24% of shares outstanding (3.71M shares) as of its latest 13F filing.
What percentage of Alto Neuroscience is owned by institutions?
Institutions own about 94.7% of ANRO shares and 99.0% of the public float.
How much of Alto Neuroscience do insiders own?
Insiders, such as officers and directors, own about 4.26% of ANRO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.